This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report +0134U for the +RNAinsight™ for CancerNext® test from Ambry Genetics, which is a targeted mRNA sequence analysis panel of 18 genes to improve variant classification of genes implicated in various hereditary cancer–related disorders. Report separately in addition to the code for the primary procedure.
For clinical responsibility, terminology, tips and additional info
start codify free trial.